Ref.: BL-RE-092539Manufacturer ref.: EM25RBX10 10 x 96 tests
€4,995.00 excl. VAT
Mouse Endostatin quantitates mouse Endostatin in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant mouse Endostatin.
Accession number
agent antiangiogénique ; COL18A1 ; chaîne collagène alpha-1(XVIII) ; chaîne collagène alpha1 de type XVIII ; collagène, type XVIII, alpha 1 ; endostatine ; FLJ27325 ; FLJ34914 ; KNO ; KNO1 ; KS ; MGC74745 ; protéine multifonction MFP ; NC1 ; domaine non collagéneux 1 ; procollagène, type XVIII, alpha 1
Dose range
2.458 to 600 ng/ml
Sensitivity of the dosage
2.5 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen
Mouse Endostatin quantitates mouse Endostatin in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant mouse Endostatin.
Mouse Endostatin quantitates mouse Endostatin in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant mouse Endostatin.
L-endostatin may cause an ununiform response to the proliferation, cell assembly and migration of endothelial cells, which have a different bonding characteristic to l-endostatin, leading to the hypothesis that the d-endostatin effect depends heavily on the endothelial cell type. In addition, l的endostatin inhibits in vivo l的angiogenesis and tumour growth by inducing apoptosis in endothelial cells. Local administration of d-endostatin appears to affect specifically microvessels associated with tumours by reducing the density, diameter and functionality of the vessel. The migration and invasion of tumour cells were significantly reduced in l-endostatin-treated animals. L的endostatin is non-toxic and does not induce any acquired resistance to drugs and has therefore become a new powerful therapy strategy in solid neoplastics. This treatment appears to have a high potential not only for the treatment of glioma, the most common brain tumours, but also for other tumours. The ability of løendostatin to inhibit neoangiogenesis is mediated, at least in part, by Zn^+2 binding and l −elastase treatment. Generalised expression of l的endostatin was detected in elactic fibers in vessel walls and in some other basal membrane areas. L的endostatin is released by neurons to accumulate in amyloid plaques in Alzheimer's disease.
Sensitivity
Sensitivity of the dosage: 2.5 ng/ml.
Measurement range
Dose range: 2.458 to 600 ng/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Reproducibility
Coefficient of intradose variation < 10%, interdose < 12%.
Target
Target: Endostatin.
Technical specifications
General
Brand
Invitrogen
Supplier ref. (Fisher Scientific)
17824230
Specifications
Accession number
antiangiogenic agent; COL18A1; collagen chain alpha-1(XVIII); collagen chain alpha1 type XVIII; collagen, type XVIII, alpha 1; endostatin; FLJ27325; FLJ34914; KNO; KNO1; KS; MGC74745; multifunctional protein MFP; NC1; non-collagen domain 1; procollagen type XVIII, alph